DiscovereBioMedicine in conversation withCarmel Harrington on butyrylcholinesterase as a potential biomarker for SIDS
Carmel Harrington on butyrylcholinesterase as a potential biomarker for SIDS

Carmel Harrington on butyrylcholinesterase as a potential biomarker for SIDS

Update: 2022-07-19
Share

Description

Dr Carmel Harrington joins eBioMedicine to discuss about their findings of a potential biomarker for sudden infant death syndrome.

Read the full article:
Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Carmel Harrington on butyrylcholinesterase as a potential biomarker for SIDS

Carmel Harrington on butyrylcholinesterase as a potential biomarker for SIDS

eBioMedicine